Optimizing antidiabetic therapy : Enhancing COVID-19 outcomes for patients with type-2 diabetes
| Errataetall: |
CommentOn: Ann Endocrinol (Paris). 2023 Aug 31;:null. - PMID 37574109 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:84 |
|---|---|
| Enthalten in: |
Annales d'endocrinologie - 84(2023), 6 vom: 01. Dez., Seite 792 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kow, Chia Siang [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 27.11.2023 Date Revised 23.02.2024 published: Print-Electronic CommentOn: Ann Endocrinol (Paris). 2023 Aug 31;:null. - PMID 37574109 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ando.2023.09.004 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363956484 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363956484 | ||
| 003 | DE-627 | ||
| 005 | 20240229145741.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ando.2023.09.004 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1304.xml |
| 035 | |a (DE-627)NLM363956484 | ||
| 035 | |a (NLM)37903668 | ||
| 035 | |a (PII)S0003-4266(23)00711-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kow, Chia Siang |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Optimizing antidiabetic therapy |b Enhancing COVID-19 outcomes for patients with type-2 diabetes |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.11.2023 | ||
| 500 | |a Date Revised 23.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Ann Endocrinol (Paris). 2023 Aug 31;:null. - PMID 37574109 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Hypoglycemic Agents |2 NLM | |
| 700 | 1 | |a Ramachandram, Dinesh Sangarran |e verfasserin |4 aut | |
| 700 | 1 | |a Hasan, Syed Shahzad |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annales d'endocrinologie |d 1946 |g 84(2023), 6 vom: 01. Dez., Seite 792 |w (DE-627)NLM000173932 |x 2213-3941 |7 nnns |
| 773 | 1 | 8 | |g volume:84 |g year:2023 |g number:6 |g day:01 |g month:12 |g pages:792 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ando.2023.09.004 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 84 |j 2023 |e 6 |b 01 |c 12 |h 792 | ||